NO983926L - Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer - Google Patents

Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer

Info

Publication number
NO983926L
NO983926L NO983926A NO983926A NO983926L NO 983926 L NO983926 L NO 983926L NO 983926 A NO983926 A NO 983926A NO 983926 A NO983926 A NO 983926A NO 983926 L NO983926 L NO 983926L
Authority
NO
Norway
Prior art keywords
inhibitor
drug
treatment
sodium hydrogen
cardiovascular diseases
Prior art date
Application number
NO983926A
Other languages
English (en)
Other versions
NO983926D0 (no
NO320264B1 (no
Inventor
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of NO983926D0 publication Critical patent/NO983926D0/no
Publication of NO983926L publication Critical patent/NO983926L/no
Publication of NO320264B1 publication Critical patent/NO320264B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
NO19983926A 1997-08-27 1998-08-26 Farmasoytisk kombinasjonspreparat omfattende en inhibitor av natrium-hydrogen-utveksler og en handelspakning omfattende dette. NO320264B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737224A DE19737224A1 (de) 1997-08-27 1997-08-27 Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen

Publications (3)

Publication Number Publication Date
NO983926D0 NO983926D0 (no) 1998-08-26
NO983926L true NO983926L (no) 1999-03-01
NO320264B1 NO320264B1 (no) 2005-11-14

Family

ID=7840257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983926A NO320264B1 (no) 1997-08-27 1998-08-26 Farmasoytisk kombinasjonspreparat omfattende en inhibitor av natrium-hydrogen-utveksler og en handelspakning omfattende dette.

Country Status (23)

Country Link
US (1) US6348476B1 (no)
EP (1) EP0937464B1 (no)
JP (1) JP4436940B2 (no)
KR (1) KR19990023904A (no)
CN (1) CN1172665C (no)
AR (1) AR017513A1 (no)
AU (1) AU738598B2 (no)
BR (1) BR9803233A (no)
CA (1) CA2245776A1 (no)
CZ (1) CZ270998A3 (no)
DE (1) DE19737224A1 (no)
HK (1) HK1018211A1 (no)
HR (1) HRP980464A2 (no)
HU (1) HUP9801924A3 (no)
IL (1) IL125913A0 (no)
NO (1) NO320264B1 (no)
NZ (1) NZ331533A (no)
PL (1) PL195566B1 (no)
RU (1) RU2227751C2 (no)
SK (1) SK116798A3 (no)
TR (1) TR199801661A2 (no)
TW (1) TW589175B (no)
ZA (1) ZA987723B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945302A1 (de) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenylderivate als NHE-3-Inhibitoren
IL147696A0 (en) * 2001-01-25 2002-08-14 Pfizer Prod Inc Combination therapy
US6423705B1 (en) 2001-01-25 2002-07-23 Pfizer Inc. Combination therapy
HUP0402593A2 (hu) * 2002-02-04 2005-04-28 Aventis Pharma Deutschland Gmbh Kariporidból és ramiprilből álló kombinációs készítmény és alkalmazása
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
RU2374224C2 (ru) * 2003-05-06 2009-11-27 Мерк Патент Гмбх Способ кристаллизации солей гуанидиния
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7531569B2 (en) 2003-12-02 2009-05-12 Sanofi-Aventis Deutschland Gmbh Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
DE10356717A1 (de) * 2003-12-02 2005-07-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten
EP1817007A2 (en) * 2004-11-05 2007-08-15 King Pharmaceuticals Research and Development Inc. Stabilized individually coated ramipril particles, compositions and methods
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556673B1 (de) 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ES2097409T3 (es) * 1992-09-22 1997-04-01 Hoechst Ag Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos.
DE4328869A1 (de) 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
BR9803233A (pt) 2000-05-02
HK1018211A1 (en) 1999-12-17
CN1172665C (zh) 2004-10-27
AR017513A1 (es) 2001-09-12
NO983926D0 (no) 1998-08-26
JP4436940B2 (ja) 2010-03-24
DE19737224A1 (de) 1999-03-18
HUP9801924A2 (hu) 2000-02-28
TR199801661A2 (xx) 1999-03-22
EP0937464A2 (de) 1999-08-25
AU738598B2 (en) 2001-09-20
KR19990023904A (ko) 1999-03-25
TW589175B (en) 2004-06-01
HU9801924D0 (en) 1998-10-28
US6348476B1 (en) 2002-02-19
ZA987723B (en) 1999-03-01
AU8190898A (en) 1999-03-11
NO320264B1 (no) 2005-11-14
SK116798A3 (en) 1999-03-12
RU2227751C2 (ru) 2004-04-27
EP0937464A3 (de) 2003-09-24
PL195566B1 (pl) 2007-10-31
PL328251A1 (en) 1999-03-01
CZ270998A3 (cs) 1999-03-17
HRP980464A2 (en) 1999-06-30
EP0937464B1 (de) 2012-07-11
CN1209316A (zh) 1999-03-03
HUP9801924A3 (en) 2004-11-29
JPH11139990A (ja) 1999-05-25
IL125913A0 (en) 1999-04-11
NZ331533A (en) 2000-04-28
CA2245776A1 (en) 1999-02-27

Similar Documents

Publication Publication Date Title
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
NO983926L (no) Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
NO20010260L (no) Tarmbeskyttelsesbelagt farmasøytisk tablett og fremgangsmÕte for fremstilling
NO20021701D0 (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
HUP0201686A3 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO996518L (no) Sertralinsalter og doseringsformer av sertralin med vedvarende frigjøring
KR970012150U (ko) 의약 및 식품용 하드 공 캅셀
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
DK40398A (da) Præparat og anvendelse deraf ved fremstilling af et lægemiddel til lindring af Dupuytren's syndrom
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20021784D0 (no) Anvendelse av dipyridamol eller mopidamol for fremstilling av et medikament for behandling og forebygging av fibrin-avhengigmikrosirkulasjonsforstyrrelser
NO20021094D0 (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
RU98116126A (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
FR2761887B1 (fr) Medicament visant a la prevention multifactorielle des maladies cardiovasculaires
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO20013145L (no) Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden
NO993784D0 (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
NO983943D0 (no) Anvendelse av inhibitorer av natrium-hydrogen-utveksler for fremstilling av et legemiddel for behandling av sykdommer forårsaket av protozoer
NO984071D0 (no) Anvendelse av hemmere av natrium-hydrogen-veksler for fremstilling av et medikament for redusering av u°nskede virkninger av stoffer pÕ hjerter